Filing Flows › CorMedix (CRMD) › Product sales, net revenue
CorMedix (CRMD) Product sales, net revenue by quarter
CorMedix's Product sales, net revenue was $94.3M in Q2 2026 (second quarter 2026), -23% from Q1 2026. Over the last 4 quarters it ranged from $94.3M (Q2 2026) to $124M (Q4 2025).
| Quarter | Product sales, net revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $94.3M | -23% | — |
| Q1 2026 | $122M | -2% | — |
| Q4 2025 | $124M | +22% | — |
| Q3 2025 | $102M | — | — |
Q2 2026 at a glance
CorMedix, Q2 2026: revenue $102M (+156% year over year), operating margin 42.1%, net earnings $26.0M, operating cash flow $86.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is CorMedix's Product sales, net revenue?
CorMedix's Product sales, net revenue was $94.3M in Q2 2026 (second quarter 2026), -23% from Q1 2026.
How has CorMedix's Product sales, net revenue changed?
Over the last 4 quarters it ranged from $94.3M (Q2 2026) to $124M (Q4 2025).